Ken Furudate
Hirosaki University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ken Furudate.
Supportive Care in Cancer | 2015
Kosei Kubota; Wataru Kobayashi; Hirotaka Sakaki; Hiroshi Nakagawa; Takao Kon; Mayu Mimura; Ryohei Ito; Ken Furudate; Hiroto Kimura
PurposeOral mucositis (OM) is a painful complication of radiation therapy (RT) for head and neck cancer. OM can compromise nutrition, require opioid analgesics and hospitalization for pain control, and lead to interruption of treatment. Severe oral mucositis appears inevitable in superselective intra-arterial chemotherapy concurrent with radiotherapy (SSIACRT), requiring management of OM for the patient. The objective of this study was to assess the utility of professional oral health care (POHC) for the management of OM in patients undergoing SSIACRT.MethodsThirty-three patients were enrolled in this study. The first 17 patients underwent SSIACRT before we created an oral management team, and thus did not receive POHC. The remaining 16 patients received POHC. Fever duration, duration of oral feeding difficulty, opioid usage, duration of opioid administration, duration of hospitalization, and number of hospital days from the end of irradiation to discharge were compared between these two groups.ResultsMedian total dose of morphine during SSIACRT, median number of hospital days from end of irradiation to discharge, and duration of hospitalization all differed significantly between groups (P < 0.05). Duration of opioid administration, fever duration, and duration of oral feeding difficulty did not differ significantly between groups.ConclusionsThese findings indicate that POHC may reduce opioid use and shorten the hospital stay. Such results might be obtained through infection control by POHC. This report appears to be the first study to evaluate the efficiency of POHC in SSIACRT for oral cancer from the perspective of mucositis pain and opioid use.
Neuroscience Research | 2015
Tadaatsu Imaizumi; Nina Sakashita; Yasuaki Mushiga; Hidemi Yoshida; Ryo Hayakari; Fei Xing; Liang Wang; Tomoh Matsumiya; Kunikazu Tanji; Yuki Chiba; Ken Furudate; Shogo Kawaguchi; Manabu Murakami; Hiroshi Tanaka
Although iron is essential in physiological processes, accumulation of iron in central nervous system is associated with various neurological diseases including Alzheimers disease and Parkinsons disease. Innate immune reactions are involved in the pathogenesis of those diseases, but roles of iron in innate immunity are not known well. In the present study, pretreatment of U373MG human astrocytoma cells with an iron chelator desferrioxamine (DFX) inhibited the expression of CXCL10 induced by a Toll-like receptor 3 (TLR3) agonist polyinosinic-polycytidylic acid (poly IC). Induction of interferon-β (IFN-β) was not affected, but phosphorylation of signal transducer and transcription 1 (STAT1) was decreased by DFX. We have previously reported that various IFN-stimulated genes (ISGs) are involved in CXCL10 induction by poly IC. Pretreatment with DFX also decreased the expression of these ISGs. Pretreatment of cells with FeSO4 counteracted inhibitory effects of DFX on ISG56, retinoic acid-inducible gene-I (RIG-I), CXCL10 and phosphorylation of STAT1. These results suggest that iron may positively regulate STAT1 phosphorylation and following signaling to express ISG56, RIG-I and CXCL10 in U373MG cells treated with poly IC. Iron may contribute to innate immune and inflammatory reactions elicited by the TLR3 signaling in astrocytes, and may play an important role in neuroinflammatory diseases.
Biochemical and Biophysical Research Communications | 2015
Yuki Chiba; Tomoh Matsumiya; Tsugumi Satoh; Ryo Hayakari; Ken Furudate; Fei Xing; Hidemi Yoshida; Kunikazu Tanji; Hiroki Mizukami; Tadaatsu Imaizumi; Etsuro Ito
Upon viral infection, the cytoplasmic viral sensor retinoic acid-inducible gene-I (RIG-I) recognizes viral RNA to activate antiviral signaling to induce type I interferon (IFN). RIG-I-like receptors (RLRs) activate antiviral signaling in a tissue-specific manner. The molecular mechanism underlying antiviral signaling in the respiratory system remains unclear. We studied antiviral signaling in the lower respiratory tract (LRT), which is the site of many harmful viral infections. Epithelial cells of the LRT can be roughly divided into two groups: bronchial epithelial cells (BECs) and pulmonary alveolar epithelial cells (AECs). These two cell types exhibit different phenotypes; therefore, we hypothesized that these cells may play different roles in antiviral innate immunity. We found that BECs exhibited higher antiviral activity than AECs. TNF receptor-associated factor 3 (TRAF3) has been shown to be a crucial molecule in RLR signaling. The expression levels of TRAF3 and TRAF5, which have conserved domains that are nearly identical, in the LRT were examined. We found that the bronchus exhibited the highest expression levels of TRAF3 and TRAF5 in the LRT. These findings suggest the importance of the bronchus in antiviral innate immunity in the LRT and indicate that TRAF3 and TRAF5 may contribute to RLR signaling.
Journal of Oral Oncology | 2014
Wataru Kobayashi; Beng Gwan Teh; Norihiko Narita; Ryohei Ito; Yuki Saito; Ken Furudate; Hiroto Kimura; Sinya Kakehata; Hideo Kawaguchi
Background. Distant metastasis is considerably more frequent in superselective intra-arterial chemoradiotherapy than other radical treatments for advanced oral cancers. However, there is no evidence supporting such claim. The purpose of this study was to report our experience in superselective intra-arterial chemoradiotherapy and conventional surgical management with particular focus on distant metastasis. Methods. One hundred seventy-two patients with oral squamous cell carcinoma in stages III and IV were included in this study. Retrospective analysis for DM rates and background between surgical management and superselective intra-arterial chemoradiotherapy was performed. Results. Distant metastasis developed clinically was detected in 24 out of 141 patients (17.0%) treated surgically and in 6 out of 31 patients (19.4%) treated with superselective intra-arterial chemoradiotherapy. There was no significant difference in the rate of distant metastasis between the 2 groups. Comparison of patients in both groups with and without distant metastasis revealed no differences in age, T classification, N classification, and treatment effect. Neck recurrence was the only significant risk factor for distant metastasis. Conclusion. No significant difference was found in the rate of distant metastasis between patients treated with surgical treatment and superselective intra-arterial chemoradiotherapy, and additional effort is needed to reduce the risk of distant metastasis.
Dental Traumatology | 2016
Ryohei Ito; Kosei Kubota; Ken Furudate; Hiroshi Nakagawa; Takao Kon; Yoshihiro Tamura; Wataru Kobayashi
A penetrating injury by a foreign body is comparatively common in the oral and maxillofacial region. On the other hand, injury to the temporomandibular joint (TMJ) by a foreign object is very rare. The TMJ is an anatomically narrow space surrounded by hard bony processes. An unusual case of trauma with severe trismus caused by a foreign body that impaled the TMJ is reported. A 55-year-old man presented with a 5 × 1-cm laceration to the right cheek caused by a flying object propelled during the use of a lawn mower. The edge of the foreign body had a metallic wire, which became imbedded in the wound. His jaw opening was severely limited. Computed tomography revealed that the foreign body was 3 mm in diameter and was impaled on the articular capsule. The object was successfully removed, and the wound and interior of the TMJ were irrigated. Rehabilitation of mouth opening was started on postoperative day 3. On day 9, mouth opening had improved to 35 mm, and he was discharged. After 1 year, mouth opening was 45 mm with no sign of any TMJ disorders.
Journal of Oral and Maxillofacial Surgery | 2018
Ken Furudate; Anna Satake; Norihiko Narita; Wataru Kobayashi
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology | 2017
Kosei Kubota; Ryohei Ito; Ken Furudate; Takao Kon; Hiroshi Nakagawa; Wataru Kobayashi
Japanese Journal of Oral and Maxillofacial Surgery | 2017
Anna Satake; Ryohei Ito; Kosei Kubota; Takao Kon; Ken Furudate; Wataru Kobayashi
International Journal of Oral and Maxillofacial Surgery | 2017
Ken Furudate; H. Sato; Wataru Kobayashi
Dental Traumatology | 2017
Ryohei Ito; Kosei Kubota; Akinari Inui; Hiroshi Nakagawa; Takao Kon; Norihiko Narita; Yoshihiro Tamura; Toshiaki Oyama; Anna Satake; Ken Furudate; Wataru Kobayashi